Results 11 to 20 of about 687 (166)

Alopecia Universalis in a Patient with Common Variable Immunodeficiency [PDF]

open access: bronzePediatric Dermatology, 1999
Abstract: A 12‐year‐old boy with common variable immunodeficiency (CVI) who developed severe alopecia is presented. His sister also had alopecia and recurrent infections and died of lung infection at the age of 7 years. The loss of hair in both children was total; the pathology of a scalp skin biopsy specimen was typical for alopecia areata.
S. sebnem Kiliç   +4 more
openalex   +5 more sources

Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis

open access: goldCureus
Objectives Tofacitinib, an effective Janus kinase inhibitor (JAKi), has gained increasing interest in recent years for the management of refractory alopecia areata (AA). One of the most prevalent autoimmune diseases is AA, a kind of non-scarring alopecia.
Syeda Shahmoona Tirmizi   +3 more
openalex   +3 more sources

Improvement of atopic dermatitis and alopecia universalis with dupilumab: a case report

open access: yesDermatology Reports, 2021
Dupilumab is an interleukin (IL)-4 receptor alpha antagonist that showed significant improvement of atopic dermatitis (AD). Many reports have shown significant resolution of alopecia areata, alopecia universalis, and alopecia totalis after dupilumab ...
Lama Alotaibi   +3 more
doaj   +1 more source

A rare case of alopecia universalis

open access: yesThe Pan African Medical Journal, 2023
A 28-year-old patient came to the outpatient department of Mahatma Gandhi Ayurved College Hospital and Research Center, Salod, Wardha with complete loss of hairs from all over the body. First, he had Alopecia areata, but then he developed complete hair loss. He took various medications but of no use. Alopecia universalis is a rare variation of alopecia
Amol Deshpande, Mayuri Deshpande
openaire   +3 more sources

Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis

open access: yesActa Dermato-Venereologica, 2023
Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the ...
Nicolae Done   +6 more
doaj   +1 more source

Hydroxychloroquine for granuloma annulare: A case report on secondary hair growth in alopecia universalis

open access: yesSAGE Open Medical Case Reports, 2023
Alopecia areata is an autoimmune disease resulting in non-scarring hair loss. Alopecia areata can progress to become alopecia totalis (loss of hair from the entire scalp) or alopecia universalis (loss of hair form the entire body), with the progression ...
Selena Osman, Danya Traboulsi
doaj   +1 more source

¿Qué esconde la alopecia? Alopecia universalis como síntoma de inicio de un paciente seropositivo al VIH

open access: yesGalicia Clínica, 2022
Highly active antiretroviral therapy has contributed to an increase of Human Immunodeficiency Virus (HIV) seropositive patients life expectancy. Because of that, comorbidities spectrum associated to this disease has been changing.
Marta Nobre Pereira   +1 more
doaj   +1 more source

HIV and alopecia universalis [PDF]

open access: yesJournal of the American Academy of Dermatology, 1993
as is usual in DDD, an increasednumber ofmelanocytes was not found in our patient, unlike the patient of Kameyama et aI. Kameyama and co-workers suggest that azelaic acid more easily penetrates active melanocytes; perhaps in our patient the melanocyteswere in a less active state.
Karla Werninghaus, Michael S. Kaminer
openaire   +1 more source

Home - About - Disclaimer - Privacy